Prognostic Relevance of Preoperative Immune, Inflammatory, and Nutritional Biomarkers in Patients Undergoing Gastrectomy for Resectable Gastric Adenocarcinoma: An Observational Multicentre Study

Jaume Tur-Martínez,Joaquín Rodríguez-Santiago,Javier Osorio,Mònica Miró,Concepción Yarnoz,Mariona Jofra,Georgina Ferret,Helena Salvador-Roses,Sonia Fernández-Ananín,Arantxa Clavell,Alexis Luna,Aurora Aldeano,Carles Olona,Judith Hermoso,Mercè Güell-Farré,Mariagiulia Dal Cero,Marta Gimeno,Natàlia Pallarès,Manuel Pera
DOI: https://doi.org/10.3390/cancers16122188
2024-06-12
Cancers
Abstract:Background: The aim of this study was to evaluate different preoperative immune, inflammatory, and nutritional scores and their best cut-off values as predictors of poorer overall survival (OS) and disease-free survival (DFS) in patients who underwent curative gastric cancer resection. Methods: This was a retrospective observational multicentre study based on data of the Spanish EURECCA Esophagogastric Cancer Registry. Time-dependent Youden index and log-rank test were used to obtain the best cut-offs of 18 preoperative biomarkers for OS and DFS. An adjusted Cox model with variables selected by bootstrapping was used to identify the best preoperative biomarkers, which were also analysed for every TNM stage. Results: High neutrophil-to-lymphocyte ratio (NLR), high monocyte systemic inflammation index (moSII), and low prognostic nutritional index (PNI) were identified as independent predictors of poor outcome: NLR > 5.91 (HR:1.73; 95%CI [1.23–2.43]), moSII >2027.12 (HR:2.26; 95%CI [1.36–3.78]), and PNI >40.31 (HR:0.75; 95%CI [0.58–0.96]) for 5-year OS and NLR > 6.81 (HR:1.75; 95%CI [1.24–2.45]), moSII > 2027.12 (HR:2.46; 95%CI [1.49–4.04]), and PNI > 40.31 (HR:0.77; 95%CI [0.60,0.97]) for 5-year DFS. These outcomes were maintained in the whole cohort for NLR and moSII (p < 0.05) but not in stage II and for PNI in all tumoral stages. The associations of NLR-PNI and moSII-PNI were also a relevant prognostic factor for OS. Conclusions: High NLR, high moSII (for stages I and III), and low PNI (regardless of tumour stage) were the most promising preoperative biomarkers to predict poor OS and DFS in gastric cancer patients treated with curative intent.
oncology
What problem does this paper attempt to address?
The aim of this paper is to address the issue of evaluating multiple preoperative immune, inflammatory, and nutritional biomarkers and their optimal cut-off values in predicting the prognosis of patients with resectable gastric adenocarcinoma. Specifically, the study aims to predict overall survival (OS) and disease-free survival (DFS) of patients by analyzing these biomarkers. The study employed a retrospective multicenter observational study design, based on data from the Spanish EURECCA esophagogastric cancer registry. Optimal cut-off values for various biomarkers were determined using statistical methods, and the predictors most associated with poor OS and DFS were selected. The study found that a high neutrophil-to-lymphocyte ratio (NLR), a high monocyte systemic inflammation index (moSII) (for stages 1 and 3), and a low prognostic nutritional index (PNI) (regardless of tumor stage) were the most promising preoperative biomarkers for predicting poor prognosis in gastric cancer patients. In summary, the key issue this paper attempts to address is identifying which preoperative biomarkers can effectively predict the long-term survival outcomes of patients undergoing curative surgery for gastric cancer.